GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Physical Therapy Inc (NYSE:USPH) » Definitions » Peter Lynch Fair Value

US Physical Therapy (US Physical Therapy) Peter Lynch Fair Value

: N/A (As of Today)
View and export this data going back to 1992. Start your Free Trial

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for US Physical Therapy's Peter Lynch Fair Value or its related term are showing as below:


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of US Physical Therapy was 6.39. The lowest was 4.24. And the median was 4.74.


USPH's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.32
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


US Physical Therapy Peter Lynch Fair Value Historical Data

The historical data trend for US Physical Therapy's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Physical Therapy Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.69 18.81 22.51 - -

US Physical Therapy Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Medical Care Facilities subindustry, US Physical Therapy's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


US Physical Therapy Price-to-Peter-Lynch-Fair-Value Distribution

For the Healthcare Providers & Services industry and Healthcare sector, US Physical Therapy's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where US Physical Therapy's Price-to-Peter-Lynch-Fair-Value falls into.



US Physical Therapy Peter Lynch Fair Value Calculation

US Physical Therapy's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *2.56
=N/A

US Physical Therapy's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.56.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


US Physical Therapy  (NYSE:USPH) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

US Physical Therapy's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=98.40/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


US Physical Therapy Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of US Physical Therapy's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


US Physical Therapy (US Physical Therapy) Business Description

Traded in Other Exchanges
Address
1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Executives
Clayton Trier director 1300 WEST SAM HOUSTON PARKWAY SOUTH, SUITE 300, HOUSTON TX 77042
Kathleen A Gilmartin director 1300 W SAM HOUSTON PKWY S, SUITE 300, HOUSTON TX 77042
Nancy Ham director U.S. PHYSICAL THERAPY INC., 1300 W SAM HOUSTON PARKWAY - SUITE 100, HOUSTON TX 77042
Richard Binstein officer: EVP Gen'l Counsel & Secretary 3733 ROSEMONT PASS, NEWTOWN SQUARE PA 19037
Edward L Kuntz director
Graham D. Reeve officer: COO 1300 W. SAM HOUSTON PARKWAY, SUITE 300, HOUSTON TX 77042
Harris Bernard A Jr director 3411 ERIN KNOLL CT, HOUSTON TX 77059
Carey P Hendrickson officer: Chief Financial Officer, other: Effective 11/9/2020 400 S. RECORD STREET, DALLAS TX 75202
Eric Joseph Williams officer: Chief Operations Officer 1300 SAM HOUSTON PARKWAY W, SUITE 300, HOUSTON TX 77042
Harry S Chapman director 4626 DRAKE FALLS COURT, KATY TX 77450
Christopher J Reading officer: Chief Operating Officer
Mark J Brookner director 1300 W SAM HOUSTON PARKWAY S, STE 300, HOUSTON TX 77042
Regg E. Swanson director, Director 1737 BURKE HOLLOW ROAD, NOLENSVILLE TN 37037
Anne Motsenbocker director 1300 W SAM HOUSTON PARKWAY, SUITE 300, HOUSTON TX 77042
Glenn Mcdowell officer: Chief Operating Officer 1300 W. SAM HOUSTON PKWY S., SUITE 300, HOUSTON TX 77042